NetworkNewsBreaks – Why Nemaura Medical Inc. (NA
Post# of 73
(Total Views: 208)
Posted On: 10/15/2021 4:11:00 PM
NetworkNewsBreaks – Why Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’
Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Founded in 2011, the company set out to create a single platform technology to measure blood markers at the surface of the skin. Since then, it has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and wellbeing. “Its flagship product, sugarBEAT(R), is a wearable, non-invasive, and flexible continuous glucose monitor (‘CGM’) designed to help people with diabetes and pre-diabetes manage their glucose levels. Insulin users can adjunctly use sugarBEAT when calibrated with a finger-stick glucose reading,” reads a recent article. SugarBEAT offers advantages such as the fact that users no longer need to draw blood samples or prick their fingers and that a person can easily wear the disposable adhesive CGM skin patch — connected to a rechargeable transmitter with a smartphone app displaying glucose readings. Existing CGM devices must be implanted under the skin. Nemaura’s already launched products include digital solutions for weight loss and potential reversal of type 2 diabetes and glucose monitoring solutions for diabetes prevention and reversal. Other products include continuous lactate monitoring for athletic performance (non-medical) and in disease state (medical), and continuous temperature monitoring for detection of viral infection and disease propagation.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Founded in 2011, the company set out to create a single platform technology to measure blood markers at the surface of the skin. Since then, it has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and wellbeing. “Its flagship product, sugarBEAT(R), is a wearable, non-invasive, and flexible continuous glucose monitor (‘CGM’) designed to help people with diabetes and pre-diabetes manage their glucose levels. Insulin users can adjunctly use sugarBEAT when calibrated with a finger-stick glucose reading,” reads a recent article. SugarBEAT offers advantages such as the fact that users no longer need to draw blood samples or prick their fingers and that a person can easily wear the disposable adhesive CGM skin patch — connected to a rechargeable transmitter with a smartphone app displaying glucose readings. Existing CGM devices must be implanted under the skin. Nemaura’s already launched products include digital solutions for weight loss and potential reversal of type 2 diabetes and glucose monitoring solutions for diabetes prevention and reversal. Other products include continuous lactate monitoring for athletic performance (non-medical) and in disease state (medical), and continuous temperature monitoring for detection of viral infection and disease propagation.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)